학술논문
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
Document Type
Article
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 December 2023, 29(24):5079-5086)
Subject
Language
English
ISSN
15573265
10780432
10780432